ANTG is a proudly Australian, independently owned medicinal cannabis focused company.
We are motivated by the possibilities and health benefits that medicinal cannabis offers.
We combine a strong research focus with best in class cultivation and extraction systems to produce exclusive high quality cannabinoid-based medical treatments that can meet individual patient needs.
“Our pioneering approach is underpinned by deep expertise and a commitment to reduce suffering and improve people’s lives through the research, development and clinical application of cannabinoid-based medical treatments”
MATT CANTELO, ANTG CHIEF EXECUTIVE OFFICER.
In the first 12 months we expect to see two tonnes plus in export. Exportation will begin to Germany, where we have signed a 10-year supply contract with Cannamedical Pharma.
The Morrison government is prioritising the medicinal cannabis industry and from September the Office of Drug Control will fast track new licences for all projects that have a big impact on exports, jobs or industry growth.
The latest national survey from Chronic Pain Australia found that more than a third of respondents said, after discussing medicinal cannabis as a pain treatment with their GP that they faced difficulty when it came around to the approval process.
We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.LEARN ABOUT ANTG HERE >